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member of the ational Road Safety Organization, members
of the medical profession, and representatives of the general
public.
Matters of principle with which the advisory council will
have to deal will include: problems of town and street plan-
ning and the building of roads; traffic regulations such a
speed limits for all kinds of vehicle, including ordinary and
power-driven bicycles, motor-cycles, motor-scooter, light and
heavy motor car (e peciaUy the large modern cars which
are capable of developing a degree of horse-power grt<atly
in excess of any driver's requirements), lorries and buses;
the establishment of a national traffic corps which should
operate on all the main roads in the country-as an exten-
sion of the services of local traffic officer ; the standardiza-
tion of the procedures of registration and re-registration of
all drivers; the formulation and implementation of com-
prehensive schemes of education in the principles of road
safety for schoolchildren and adults; sustained imaginative
publicity; and systematic research into all the important
human and technical facets of the problem of road safety.
Secondly, it is our firm conviction that effective action
on the individual level is as indispensable as the measures
c.arried out on a national level. We should be lulled into
a false and dangerous sense of security if we were to believe
that a national traffic organization would exempt us, as
individuals, from all responsibility in this vital matter.
Indeed, in this as in all other problems of community life,
we have to rely ultimately on the individual conscience and
sense of responsibility in every person if we hope to achieve
a stable and satisfactory way of life.
Some of the aspects of this problem which may be re-
garded as matters of personal responsibility, are: the con-
tinual cultivation and stimulation of a social and road
conscience and of courtesy and goodwill; and a realization
of the imminent dangers of the use of alcohol by drivers,
of speeding and the many forms of immature behaviour
of motorists, who feel the need for bolstering their egos by
their flamboyant driving leading so often to fatal accidents.
In the matter of our complicated modem traffic system,
as in all other matters touching on our community life,
we, as responsible and civilized people, will have to realize
the urgent need for cooperative action as individuals, groups
and organizations, in negotiating our way through the world
with a greater measure of safety and security for all.
1. du Toit, J. G. (1959): S. Arr. Med. J., 33, 296.
2. Correspondence (1959): Ibid., 33, 447.
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It is less than 30 years ago that the first extracts of the adrenal
cortex were used experimentally to prolong life in adrenalecto-
mized animals l and purified extracts ('cortin') were employed
in ca es of Addison's disease. While the use of 'cortin'
and subsequently desoxycorticosterone (synthesized in 1937)
was accepted substitution therapy, it was well established
that the 'amorphous fraction' of the adrenal extract or
whole adrenal preparations had more potent action on
organic and mineral metabolism in adrenal insufficiency
than crystalline preparations. Further, when cortisone and
cortisol became available 10 years ago, it was soon evident
that doses adequate to normalize organic metabolism lacked
capacity to maintain normal salt metabolism.
Discovery of the Salt-regulating HornlOne of the Adrenal
Cortex
Recent developments in biochemical techniques, particular-
ly chromatography, have led to the isolation of a considerable
number of discrete steroids (corticoids, androgens, pro-
gestogens and oestrogens) from the adrenal glands. The
division into gluco- and mineralo-corticoids, particularly
stressed by Selye, is really only relative, since each steroid
has effects on organic and salt metabolism in variable degree.
Examination of adrenal-vein blood and effluents from per-
fused glands indicated that the major active secretion in
man is cortisol, with lesser amounts of corti one and corti-
costerone; in other mammals, corticosterone formed a
greater proportion of the secreted corticoids.2 Consideration
of desoxycorticosterone as a hormone has been controversial,
since for many years after its discovery this steroid could
,. Revision of talk to the S.A.I.M.R. Scientific Club, Johannes-
burg, 12 May 1958.
not be detected in adrenal-vein samples. Further, despite
recent identification of desoxycorticosterone in adrenal-vein
blood and perfusates,3 the amounts do not appear to be
adequate for significant biological action. At best, desoxy-
corticosterone only resembles in part the action of a natural
electrolyte-regulating adrenal hormone.4
Isolation of aldosterone. The impetus for the isolation
and characterization of a natural salt-retaining hormone
was provided by the work, starting in 1950, of Luetscher
and his associates. 5 ,6 They found high titres of a sodium-
retaining substance in the urine of patients with oedema,
by assay of urinary extracts injected into adrenalectomized
animals (it is a curiosity of nature that the best source of
aldosterone at present is the urine of nephrotics, whose
daily excretion may be 0,05-0· 2 mg.). Subsequently, the
Simpson and Tait group from Middlesex Hospital, using
chromatographic methods for steroid separation just
published by Bush' in England and Zaffaroni8 in the United
States, and increasing the sensitivity of the bio-assay test
by using flame photometric and isotopic measurement of the
urinary a/K ratio, isolated a highly potent, pure salt-
retaining hormone ('electrocortin') from the 'amorphous
fraction', adrenal-vein blood and urine in 1952.9-11 This
constituted adequate evidence that 'electrocortin' is a normal
secretory product of the adrenal gland; it is now generally
accepted that it accounts for about 75 %of the salt-regulating
activity of the adrenal gland.
The chemical constitl/tion of the salt-retaining hormone
gave rise to much speculation, until finally the Middlesex
and Basle workers in collaboration12 determined its formula
in 1954 (Fig. I). From the figure it is seen that crystalline
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Fig. 1. Chemical structure of aldosterone. I--Corticosterone.
II-Desoxycorticosterone. Aldosterone (crystalline) - note
l8-aldehyde group. Aldosterone (in solution)--note 11-18
hemiacetal group.
aldosterone has the same basic structure as corticosterone
and desoxycorticosterone and is, in fact, the 18-aldehyde of
corticosterone (whence its name). Subsequently, independent
confirmation came from various sources and Luetscher's
salt-retaining substance in nephrotic urinesl3 was shown to
be aldosterone. The structure of aldosterone is unique
among biological steroids in that it (a) has an 18-group,
and (b) exists largely in solution in an hemiacetal form.
This may account for its great biological activity, since
recently the aCetal preparations of cortisol and prednisolone
have been shown to have many times the activity of the
parent substances.14
Biosynthesis 0/ Aldosterone
The demonstration by the Tait groupl5 that incubation
of beef adrenal-gland capsules gave the highest yield of
aldosterone has located the site of formation in the zona
glomerulosa. Decapsulated glands yielded little or no
aldosterone, nor did incubation of separated fasciculata-
reticularis zones. Tbis observation has been confirmed for
the rat adrenal,IS and Conn's suggestion that the adenoma
of the first described case of Conn's diseasel7 arose in the
zona fasciculata would appear to be in error. The present
source of crystalline aldosterone is by isolation from beef
or hog adrenal (0·05-0·1 mg.jkg. in beef and up to 10
times as much in hog adrenal glands). Recently, the chemical
synthesis of aldosterone by different processes has been
announced,IS,19 and tbis will, it is hoped, solve the supply
problem in therapy and investigation.
Evidence is accumulating that aldosterone is also formed
in the placenta.20
Nature 0/ adrenal precursors 0/ aldosterone. Incubation
of adrenal tissue from various animals with different steroids
has resulted in somewhat different findings, probably related
to slight variations in experimental conditions. However,
in essence, progesterone, desoxycorticosterone and corti-
costerone (and only these steroids) all increase aldo terone
production ill vitro. In the conversion of cholesterol to
adrenal steroids, progesterone i an es ential intermediate.
This keystone teroid leads to the formation of adrenal
androgens, oestrogens and cor!isol (with cortisone as its
by-product) by one major metabolic pathway, and deso y-
corticosterone, with corticosterone and aldosterone derived
from it (Fig. 1) by a econd major conversion.
Metabolism 0/ Aldosterone
Knowledge of the metabolism of aldosterone has been
considerably extended in the past year by the administration
of HC-steroids and more recently of 16-sH progesterone
(with much higher specific activity) in animal and human
experiments. Human secretion of aldosterone may be put
at 0·2 mg.jday on normal salt and 0·8 mg.jday on low salt
intake (by comparison, normal secretion of cortisol is 25
mg.jday). Blood concentration is probably 0·05 microgram
% (compare cortisol, 10 microgram %). At present the
only feasible blood method is that of isotopic dilution,
with "addition of radioactive aldosterone ill vitro.
A further difficulty in the study of aldosterone metabolism
is that urinary excretion ranges up to 0·0I mg.jday, depending
on the variation in normal salt intake. Since this represents
only some 5 % of the daily secretion, and other aldosterone
metabolites in the urine amount to less than 20%, correlation
of urinary aldosterone content and adrenal secretion may be
misleading. evertheless, urinary aldosterone estimation
is at the moment the only feasible method of assessing
adrenal secretion of salt-regulating hormone. Most labora-
tories are abandoning the bio-assay technique for chroma-
tographic methods21.23 (the author had the opportunity of
developing a modification of a method21 in the Department
of Chemical Pathology, King's College Hospital Medical
School, London). For any degree of accuracy, the methods
are complicated and tedious, require great attention to
technical detail, and must perforce remain in the sphere of
special investigation.
Function 0/ Aldosterone
Life maintenance. Doses of 0,001-0,002 mg.jkg.jday
maintain life and electrolyte balance in adrenalectomized
animals and Addisonian patients. Higher doses may cause
some salt and water retention, but not when cortisol is given
concurrently. "
Electrolyte effects. Aldosterone influences the distribution
of sodium and potassium (and magnesium) between the
intra- and extracellular compartments by increasing the rate
of exchange between cell potassium and magnesium and
extracellular sodium-thus decreasing sodium and increasing
potassium and magnesium in saliva, sweat, urine, etc.
Quantitatively, its action on urinary composition is of
particular importance, since it enhances the exchange of
sodium in the tubular fluid for cellular potassium in the
distal convoluted tubule (Fig. 2). Aldosterone has some 250
times the sodium-retaining potency of cortisone or cortisol
for equivalent dose and 30 times that of desoxycorticosterone,
and is approximately equivalent to the synthetic 9oc-fluoro-
hydrocortisone. Aldosterone has 5 times the activity of
desoxycorticosterone in enhancing potassium excretion.
Effects on water excretion. The end-result is dependent
on the interplay of steroid action on sodium excretion,
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Fig. 2. Action of mineralocorticoids on the renal tubule.
G-Glomerular filtrate: 600-800 mEq. K, 18,000-25,000
mEq. Na. P-Proxirnal tubule: all K reabsorbed, 85-90%
Na reabsorbed. D-Distal tubule: Na-K and Na-H ex-
change modified by aldosterone.
the latter either by local action or conditioned by steroid
effect on the secretion of antidiuretic hormone (ADH)-
thus adrenal corticoids may be diuretic or antidiuretic
according to the steroid, the dose and the particular physio-
logical or pathological conditions operating at the time.
For example, while aldosterone has been reported to have
no direct effect on water excretion nor to repair the inability
of the adrenalectomized dog or Addisonian patient to
excrete a water load, other studies have indicated that this
steroid can increase glomerular filtration and produce
diuresis in adrenalectomized rats.'
The glucocorticoid effects of aldosterone are as follows:
(a) Carbohydrate metabolism: Aldosterone deposits liver
glycogen, having 1/4th - 1/3rd the activity of cortisone and
25 times that of desoxycorticosterone.
(b) Stress: Aldosterone is more effective than cortisone
or desoxycorticosterone in protecting against cold stress.24
The excretion of aldosterone is increased in heat stresS.25
(c) Connective tissue: Aldosterone has no anti-inflamma-
tory or allergic action, nor does it inhibit granuloma forma-
tion.
(d) ACTH release: Unlike cortisone or cortisol, aldosterone
does not suppress endogenous pituitary adrenocortico-
tropin.
Blood pressure. Aldosterone produces none of the
pathological changes seen with desoxycorticosterone of
equal sodium-retaining potency. However, high dosage
combined with high salt loading has produced hypertension
in rats, with renal and vascular changes of mild degree.'
Control 0/ Aldosterone Secretion
The stimulus to aldosterone secretion arises as a hypo-
thalamic neuro-hormone, postulated to result from altera-
tions in effective blood volume, which acts on hypothetical
volume receptors26 (? sited in lungs, heart atria,27 arterial





o hours and (2) appears to react more to rapid blood VOlumechanges than slow; and (3) effects on renal electrolyte excretion
follow several hours after alterations in aldosterone secretion.
The neuro-humoral transmitter must be regarded as
separate from ACTH action, since aldosterone continues to
be secreted at about 50 % of normal rate after hypophysec-
tomy and continues virtually unaltered after ACTH adminis-
tration. The administration of ACTH in therapy or to
normal individuals produces a small increase of aldosterone
secretion. Similarly, suppression of endogenous corticotropin
with large doses of cortisone alters aldosterone secretion to
a slight degree.
However, by the use of purified ACTH fractions, FarrelI
et al. 28 has shown that A-eorticotropin, comprising about
10% of his ACTH preparations, had 20 times the aldosterone-
stimulating activity compared with B-eorticotropin, so that
variation in the amounts of the different components in
therapeutic preparations or actually secreted by the pituitary
gland will account for variation reported by different in-
vestigators. In any event, it is apparent that the secretion
of aldosterone is not under complete and direct control
by ACTH. The complexity of the problem is indicated by
the fact that injection of growth hormone in animals and
man appreciably increases the secretion of aldosterone.
If the effective blood volume is the stimulus to the







increased sodium tubular reabsorption
(increased urinary potassium)
increased body sodium and extracellular tonicity
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(increased water intake)
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Fig. 3. Homeostatic regulation of extracellular fluid. Aldos-
terone controls body 'sodium (slow action). ADH controls
body water (rapid action).
be postulated to occur as a dual 'feed-back' mechanism
(Fig. 3). Allied to this homeostatic regulation of body
fluid, consideration must be given to the possibility that
changes in blood volume or flow may alter the flow through
the liver and so alter the degree of hepatic inactivation of
aldosterone and ADH.
The stimulus continues to act if the compensating
mechanisms cannot function. For example, large amounts
of aldosterone are present in the urine of cirrhotic:> \vith
ascites, since the retained fluid fails to inactivate the retention
mechanism because the fluid becomes progressively segregated
in a non-circulating compartment.
Increased secretion of aldosterone (indicated by elevated
urinary aldosterone) occurs (I) during deprivation or de-
pletion of sodium and (2) during addition of potassium.
Apparently the potassium loading must cause sodium loss
to produce the increase in secretion. Since haemorrhage,
sweating, diamox diuresis etc. all increase aldosterone
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secretion, the common factor is sodium and water loss,
i.e. loss of body fluid. 29 Conversely, sodium addition and,
to a lesser extent, potassium depletion depresses aldosterone
secretion.
While the secretion of aldosterone is subservient mainly
to the requirements of body-fluid volume control, other
factors, e.g. sodium excretion,' renal haemodynamics, con-
centration oftissue electrolytes etc. are probably also involved.
CLINICAL ALDOSTERONISM
]n retrospect, it is apparent that aldosterone dysfunction
was responsible for many of the signs and symptoms in
adrenal insufficiency; yet, on the other hand, Cushing's
syndrome shows no clear signs of aldosterone hyperfunction.
This is due to the fact that other adrenocortical hormones
have effects on mineral metabolism; for example, the daily
secretion of cortisol is about 100 times that of aldosterone,
so that although the electrolyte action of cortisol on an
equivalent weight basis is small compared with aldosterone,
its total effect is quite considerable, apart from qualitative
differences in its electrolyte effects. The relative proportions
of secretion and inactivation of corticosterone, cortisol and
aldosterone control the net effect of the adrenal cortex on
electrolyte metabolism.
Syndromes of Primary Hyperaldosteronism
l. Aldosteroma (Conn's Disease)
Excessive wastage of potassium by the kidneys, with
severe and persistent hypokalaemia leading to periodic
paralysis, had for some years been attributed to a primary
renal lesion, viz. potassium-losing nephritis. 30-33 However,
Conn, finding low Na/K ratios in excretory body fluids in
a similar case, together with a sodium-retaining factor and
no increase in 17-hydroxycorticoids in the urine, concluded
(October 1954) that the excess excretion of electrolytes might
be due to overaction of the then newly discovered hormone,
aldosterone.17 Exploration revealed .an adrenal adenoma,
removal of which cured the disorder. 34,35 Once the cause
had been found, several cases of 'potassium-losing nephritis'
were identified as Coon's disease in retrospect, adrenocortical
adenomata being found at operation or post mortem and
indicating clearly that the patients had been suffering from
primary aldosteronism.
To date, some 35 cases are recorded in the literature and
others are known to the author. They occur mainly in
adults. An interesting feature of the first 15 cases described
is that symptoms had been present for long periods (t - 15
years) and that the patients had been admitted on several
occasions before the correct diagnosis was made. The
clarification of the aetiology and symptomatology is a
considerable advance for this essentially remediable condition.
Clinical features. The characteristic signs in the fully
developed case may be classified as follows:
(a) Severe electrolyte disturbances-hypokalaemic, hypo-
chloraemic alkalosis, with gross body-potassium depletion;
high normal or raised plasma sodium.
(b) Attacks of muscular weakness or paralysis, with
occasional paraesthesiae or tetany. Despite considerable
potassium depletion, most patients are surprisingly well
between attacks.
(c) Hypertension, moderate to severe. Every case of
hypertension with neutral or alkaline urinary pH: in a young
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person should probably have plasma-potassium and bicarbo-
nate estimations and a potassium-repletion test done (followed
by steroid studies if required).
(d) Widespread impairment of kidney function-polyuria;
inability to concentrate urine; iow maximum urinary specific
gravity resistant to pitressin; alkaline or neutral pH with
little response to ammonium-chloride administration; inter-
mittent proteinuria; and reduced clearances. The changes are
partly or completely reversed when the potassium deficiency
is corrected by removing the adrenal adenoma. Since
experimental potassium depletion or deficiency from extra-
renal causes leads to similar renal effects, the urinary altera-
tions may be attributed in major degree to potassium
deficiency. Once the condition has been present for several
years, clear-cell nephrosis and nephrosclerotic changes may
supervene, with hypertension and pyelonephritis (potassium-
depleted kidneys secreting an alkaline urine are prone to
infection). ]n these cases, recovery of renal function may
be incomplete once the tumour has been removed.
(e) Endocrine aspect. The reported values for urinary
aldosterone in Conn's disease are not impressively in-
creased;36 they may be at upper normal or slightly raised
levels, and are noticeably less than in secondary hyper-
aldosteronism. The problem arises, how can such levels
account for the severe electrolyte and hypertensive dis-
turbances? Undoubtedly a time factor is involved. No
urinary aldosterone values are yet available for the early
stages in the development of the aldosteroma; once the
condition is fully developed, the body-potassium depletion
will considerably reduce the secretion of aldosterone from
normal adrenal tissue.
Diagnosis of Aldosteroma
]n the fully developed case, the combination of history,
signs and the assembly of biochemical and radiological
(air insufflation to demonstrate adrenal tumour) data are
sufficiently clear-cut to make a probable diagnosis fairly
certain in the light of current knowledge; however, in the
early stages of the condition, the mildness of the symptoms
make the diagnosis more uncertain. Early operation is of
some importance, since renal changes produced by persistent
potassium deficiency eventually become irreversible; however,
considerable correction of electrolyte and renal abnormalities
can be produced with potassium supplements and a low-
sodium diet.
The progressive changes produced by the hormonal
disorder and the considerable range of presenting symptoms
is well illustrated in 2 case reports by Milne and Muehrcke. 37
The one case was a most s~vere example with a 12-year
history of prolonged hypokalaemic paralytic episodes (up
to 21 days in duration) and irreversible renal failure. This
patient had been previously diagnosed as 'potassium-losing
nephritis' ;31 considerable improvement followed the removal
of an adenoma. 38,38a The other subject was asymptomatic
except for slight hypertension and an electrocardiogram
suggestive of potassium depletion. Renal biopsy was normal,
and perirenal air insufflation showed no tumour, but some
potassium deficiency with excess urinary loss was found.
At operation the smallest adrenal adenoma (1' 5 cm.) yet
recorded was found. The difficulties in diagnosis presented
by this case are also reflected in a report by Crane et al. 39
The patient had hypertension with occasional attacks of
polydipsia. A left Smithwick sympathectomy was done, and
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the left adrenal was seen to be normal at the operation.
With no improvement in blood pressure and the finding of
transient muscular weakness and hypokalaemia, an adenoma
of the right adrenal gland and the right sympathetic chain
were removed at a second operation, with disappearance
of symptoms. In retro pect, it is evident that removal of
the adenoma alone would have cured the disorder.
To date, practically all the reported ca es of Conn's
disease had had more than one admi sion before Conn's
paper'7 indicated the correct diagnosi. In the first
described case from South- Africa, Eales and Linder4° con-
cluded, at the time of her discharge (June 1953) after the
first admission, that the patient had renal disea e and that
activity of a 'DOCA-like' substance was responsible for the
hypernatraernic, hypokalaemic alkalosis; after several epi-
sodes of muscular weakness, a second admission disclosed
no change in electrolyte abnormalities, but the patien"t
remained well provided she took supplemental potassium
(September 1954). In October 1955 readmission for air
insufflation studies revealed a left adrenal tumour, and the
adenoma was successfully removed, with disappearance of
symptoms.
Brooks et al. 36 and Milne and his collaborators,37.38,38a
discuss the considerable difficulties encountered in distinguish-
ing between potassium deficiency due to renal tubular or
adrenal cortical origin. While renal tubular acidosis is rare
in adults and can be identified by hyperchloraemic acidosis
with a neutral or acid urine, potassium-losing pyelonephritis
etc. are not readily differentiated from aldosteroma with
secondary renal changes.
For the differential diagnosis, the measurement of urinary
aldosterone is complicated, tedious and more difficult to
interpret than a study of potassium balance and renal
function. Asymptomatic hypokalaemia may be the earliest
presenting sign. A repletion test with potassium will indicate
the degree of body-potassium depletion, and a continuance
of low plasma potassium with excessive urinary potassium
loss indicates the resistance of the mineralocorticoid excess
to correction of the potassium deficit. In mild cases, potas-
sium loss on a low potassium intake will expose the inadequate
renal conservation of potassium; but in a case with definite
symptoms such a test would precipitate a severe reaction.
Alkalosis and hypochloraemia without obvious cause is
suggestive; so is benign hypertension in association with an
alkaline urine not due to an active urinary infection. The
reduced salivary sodium and increased K/ a ratio are
considered valuable evidence by some investigators. However,
the author has found that only estimations on pure salivary
juice under controlled conditions provide a range of normal
values to permit assessment of deviations; this finds con-
firmation in tbat examination of reported values from
aldosteroma cases shows no clear-cut characteristic values.
Excess urinary potassium, with polyuria somewhat resistant
to ADH, and a neutral or slightly alkaline (fresh and negative
for bacteria) urine with a slight or moderate response to
NH4Cl administration, is evidence of renal changes secondary
to the steroid-induced potassium deficiency.
Tbe ultimate diagnosis rests on surgical procedures-renal
biopsy, perirenal air insufflation to outline the adrenal gland
for-radiological examination, and operation by th~ abdominal
route so that both adrenal glands can be examined. In the
majority of aldosteromas reported to date, only operation or
post-mortem provided certain diagnosis.
2. Variants oj Conn's Disease
Oedema is not a feature in Conn's disease. However, cases
have been reported with oedema and the classical signs
described by Conn, and in which, on removal of an adrenal
adenoma, the oedema, electrolyte abnormalities and hyper-
tension41 disappeared. The possibility that other sodium-
retaining hormones with qualitatively different effects are
.ecreted by the adrenal cortex requires investigation in such
instances. .
Several clinicians have reported the occurrence of mild
diabetes mellitus associated with proven aldosteromas.42,43
The glucocorticoid activity of aldosterone is relatively slight,
and whether one is dealing with a random association or
with diabetes mellitus caused by adrenal steroid (or steroid
glucosuria) must await further investigation and reports
in other cases.
3. Mineralocorticoid Excess and Mixed Syndromes
Apart from localized adenomas of the adrenal (al-
dosteromas), hyperplasia of the adrenal cortex32,44-46 and
primary36,47 and secondary48 carcinoma produce symptoms
almost identical with those described by Cann. l7 ,34,35 Cases
with proved a!dosteromas should be called Conn's disease,
and other primary adrenal cases with no obvious alteration
in glucocorticoid junction would be classified as Conn's
syndrome.
The reported cases of hyperplasia of the adrenal cortex
leading to Coon's syndrome have occurred almost entirely
in children, with a decrease or disappearance of symptoms
on partial or total adrenalectomy. Cerebral disturbances44,4s
(hyperpyrexia, convulsions), presumably resulting from
excessive hypothalamic stimuli to the adrenal cortex, are
considered causative in 2 cases. The rates of secretion of
aldosterone and of cortisol can be differentially affected by
experimental brain-stem lesions in animals.49 The relationship
between these two cases and the condition of cerebral hyper-
natraemia and the secondary hyperaldosteronism of idio-
pathic oedema (discussed below) is obscure at the moment.
While it is noteworthy that none of the described cases
of Conn's disease and syndrome have the usual signs of
Cushing's syndrome, it is probable that pure aldosteromas
or conditions of specific hypersecretion of aldosterone are
rare. Tumours or hyperplasia of the adrenal cortex may
involve the secretion of aldosterone, corticosterone, cortisol
and other adrenocortical hormones in varying degree. This
would alter the amount and proportion of sodium retained
and potassium excreted and thus the total mineralocorticoid
effect. Further, mixed syndromes of mineralo- and gluco-
corticoid hyperfunction are being recognized. For example,
cases of Cushing's syndrome frequently show decreased
plasma and body potassium and, where such cases have been
examined, the urinary adrenocortical hormones indicate
normal or subnormal aldosterone with increased cortisol
and corticosterone. 50 Cases of salt-losing adrenogenital
syndrome exhibit norma! urinary aldosterone values;Si.S2
although the synthesis of cortisol has been shown to be
defective, with deviation of steroid metabolism to produce
excessive amounts of urinary pregnanetriol, a theoretical
salt-losing hormone is also considered to be a possible cause
of the sodium loss.
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Secondary Hyperaldosteronism
In a wide range 'of conditions, urinary aldosterone ex-
cretion increases as a result of abnormalities situated outside
the adrenal gland, which responds in a normal manner to
the stimuli. The most notable increases occur in conditions
of oedema, where the secretion of other adrenocorticoids
may be virtually normal. The' considerable electrolyte dis-
turbances, with little or no oedema and moderate iI;lcrease
in urinary aldosterone, of the fully developed primary disease
contrast sharply with the preponderant fluid disturbances
and greater aldosterone output in oedematous conditions.
While the volume-control theory (Fig. 3) fits many of the
observations in secondary hyperaldosteronism, some in-
vestigators are not prepared to accept it as valid; e.g. Conn
states, 'Precise physiological or biochemical stimuli for·
secondary aldosteronism are unknown'.
1. Oedema and Aldosterone
The triad of oedema, sodium retention and elevated
urinary aldosterone is only found in severe forms of
congestive heart failure, in liver cirrhosis with ascites,.in
nephrosis, in pregnancy with and without toxaemia, and
in idiopathic oedema. The effective blood volume is low
in these cases from other factors (abnormal peripheral
and renal haemodynamics, hypoproteinaemia, etc.) and the
excess fluid or oedema is segregated in a non-circulating
form. .
This constitutes a continuing stimulus to an increased
production of aldosterone, accentuated since such cases
have been· salt-restricted or under diuretic therapy for some
time. In addition, diminished effective flow through the
liver and other organs may decrease the inactivation of
aldosterone. Normally, about 5 % of secreted aldosterone
is excreted in the urine in a biologically active form. The
possibility arises that in these conditions more free
aldosterone is excreted, with an enhanced effect on sodium
reabsorption in the renal tubule.
In heart disease the excretion of aldosterone is normal and
increases only occur secondarily to the development of
cardiac cirrhosis with decreased inactivation of free
aldosterone, and oedema asa result of altered peripheral
and renal haemodynamics. Therapy aimed at sodium
depletion is a further potent stimulus to aldosterone secre-
tion. 53 The disturbance in fluid distribution and sodium
metabolism (the reduced effective intravascular volume being
the critical factor) fails to inactivate the retention mechanism
and reduce aldosterone activity. Sodium and water will
be continuously retained until the cycle is broken by rest,
digitalis and diuresis. High urinary aldosterone values are
associated with intractable oedema and low urinary sodium.
In liver disease there is evidence of increased urinary
aldosterone.· This is due to reduced hepatic inactivation of
aldosterone, 54 as a result of which a higher proportion of
biologically active hormone circulates and is excreted in
the urine. The detection of metabolic products of aldosterone
in urine will enable this aspect to be clarified. In hepatic
cirrhosis with ascites, the urinary aldosterone rises rapidly
with the reaccumulation of ascitic fluid after paracentesis.
It is thus probable· that the increase in salt-retainiiJg hormone
follows the collection of peritoneal fluid precipitated by
portal h~rtension. The progressive shift of fluid into a
segregated compartment leads to further activation of the
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dual retention mechanism in an attempt to replace sodium
and water losses and to prevent hypovolaemia. The failure
of the retained sodium and wRter (because it is not part of
tile effective blood volume) to reduce aldosterone and anti-
diuretic hormonal activity results in continuous odium
and water retention by the kidney, unless the cycle i broken
by reduction of portal hypertension, restoration of the
normal osmotic pressure of the blood, and sodium restriction
or diuresis.
In nephrosis the aldosterone excretiop is greatest during
the accumulation of oedema consequent on a decrease in
circulating blood volume as a result of hypoproteinaemia.
Injection of concentrated human serum albumin or prednisone
decreases urinary aldosterone output, but only when diuresis
occurs.
In toxaemia ofpregnancy the urinary aldosterone excretion
is considerably elevated. However, the increase in aldosterone
output only contributes in part to the sodium and fluid
retention, since increases in aldosterone excretion of a
greater magnitude occur in normal pregnancy.55,56 Several
operative mechanisms may be suggested: impaired hepatic
inactivation of active aldosterone; alteration in the propor-
tion of aldosterone, cortisol, and other hormones secreted by
the adrenal; adrenocortical response to maintain effective
circulating blood volume in the face of sodium and water
loss into maternal and foetal cells; and compensatory
response for ·the sodium-diuretic properties of the increased
progesterone output.
Cases have been described in women with emotional
stress and tension, of idiopathic oedema, in which the only
prominent sign was an increased output of aldosterone. 57· 59
The condition was unrelated to the menstrual cycle and the .
oedema subsided on a low-sodium diet. Partial adrenalectomy
did not improve the condition in those operated on, nor
was any abnormality of the adrenal gland found. A persistent
stimulus to, the zona glomerulosa of the adrenal cortex
from hypothalamic or higher centres is postulated.
A case of massive oedema with sodium retention and no
evidence of disease of the heart, liver or kidney illustrates the
many complexities in the study of aldosterone function. 60 ,60a
The patient had had oedema since 1945 attributable to abnor-
mal capillary permeability to proteins (high protein content of
pleural and oedema fluids). When aldosterone estimations
became available, high urinary values were found associated
with very low urinary sodium., On exploration, the left
adrenal gland containing an adenoma was removed (none
of the symptoms and signs of primary hyperaldosteronism
were present), with subsequent adequate excretion of sodium
and normal urinary aldosterone levels. Six months later,
urinary aldosterone again became elevated and only minimal
amounts of sodium were being excreted, and a hypertrophied
right adrenal gland was then removed. The continued
attempts to reduce sodium intake and induce sodium ex-
cretion by vigorous diuretic and other therapy led to excessive
secretion of aldosterone. The adenoma was functional
and the adjacent adrenal tissue contained no aldosterone.
With the continuance of the stimulus, the remaining adrenal
gland then proceeded to produce excessive amounts of
aldosterone. The original cause of oedema persists-when
the patient's weight falls below a certain level, symptoms
of sodium depletion occur and oedema ensues on sodium
administration.
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. 2. Hyperaldosteronism withollt Oedema
Experimentally, aldosterone is less l1able to produce
hypertension than desoxycorticosterone or cortisol with
steroid overdosage. Patients with severe benign hypertension
have a slight increase of urinary aldosterone/' but the in-
crease is moderate and may be related to a deviation in salt
intake or metabolism in hypertensives.
Cerebral damage, with the development of chronic hyper-
natraemia and alkalosis, may result from hypothalamic
stimulation of the aldosterone-secreting cells of the adrenal
cortex.62
In sodium-losing nephritis of long standing, the sodium
depletion will invoke a secondary hyperaldosteronism;83
according to the degree and duration of aldosterone hyper-
activity, potassium excretion may then increase and renal
changes due to potassium deficiency may be superimposed
on the original defect.
3. Temporary Hyperaldosteronism.
Certain conditions produce an episode of increased urinary
aldosterone without oedema. Raised levels of urinary
aldosterone (and cortisol) with associated retention of
sodium and water and increased excretion of potassium
occur in the immediate post-traumatic84 and post-operative"s
periods. Although the factors involved are necessarily
complex, loss of fluid and electrolytes and circulatory in-
adequacy may be responsible for evoking the adrenal response.
Haemorrhage (phlebotomy) will increase urinary aldo-
sterone,29,66 and so will exposure to high environmental
temperatures. 2S ,67 It is noteworthy that not all stress factors
will increase urinary aldosterone (and cortisol); for instance,
hard physical exercise has no effect. .
In periodic paralysis intermittent aldosteronism occurs
(Conn et 01.68); both spontaneous and induced paralysis is
preceded by large increases in urinary aldosterone and
intense sodium retention, followed by excessive loss of
potassium. With subsidence of the attack, considerable
sodium diuresis occurs, with decrease in urinary aldosterone
to normal. Conn concludes that intracellular transfer of
sodium precipitates the attack of paralysis and may be
prevented or decreased in severity by a low-sodium diet.
HYPO-ALDOSTERONISM
Primary Hypo-aldosteronism
A primary decrease in aldosterone secretion with otherwise
unaltered adrenocortical function has been reported.69,70
ne patients had clinical signs attributable to hyperkalaemia
(including heart block69), and also hyponatraemia and
absence of demonstrable urinary aldostef0ne with normal
excretion of other adrenocortical hormones and no evidence
of renal dysfunction. As yet, it is not possible to con-
clude whether the primary error is in the adrenal gland
or affects some extra-adrenal regulatory mechanism.
In the hypo-adrenocorticism (decreased aldosteroI\e and
cortisol) of Addison's disease or in adrenalectomized subjects,
the inadequacy of electrolyte regulation is rapidly demon-
strated by any measure that would normally increase the
secretion of aldosterone, viz. sodium deprivation or excessive
intake of potassium. Neither aldosterone nor cortisone
alone is effective in the treatment of adrenal insufficiency.
The adrenal crisis that may develop in hypopituitarism
shows decreased secretion of cortisol, but urinary aldoste-
rone is usually within normal limits, as would be expected
since aldosterone secretion is only slightly influenced by
pituitary secretion.
Secondary Hypo-aldosteronism
A transient hypo-aldosteronism occurs after removal of
the aldosteroma, until the secretion of aldosterone by the
normal adrenal tissue 'revives'. A more persistent decrease
in aldosterone excretion occurs during renal insufficiency,
oliguria or acidosis; this may be a reflection of potassium
retention.
Various drugs decrease the secretion of aldosterone.
Amphenone reduces biosynthesis and the release of al-
dosterone, and of other adrenocortical hormones to a lesser
degree.71 Similarly, the insecticide DDD and pinacolone
compounds decrease adrenocortical secretion.7Z Prednisone
reduces aldosterone activity, either by hypothalamic action
or by competition in the electrolyte reabsorptive process
of the renal tubule. Synthetic 'spirolactone' steroids,
apparently antagonistic to the action of aldosterone or
desoxycorticosterone on renal tubular cells, have recently
been developed with potent sodium-diuretic effects in the
presence of these two mineralocorticoids.73,74
SODIUM-RETAINING AND SODIUM-DIURETIC HORMONES
Comparison of normal ·secretion rates and the sodium-
retaining capacities of adrenocortical hormones brings out
the fact that cortisol, secreted at 25 mg./day, has only slightly
less total influence on sodium retention than aldosterone
(secretion, O' 2 mg.jday), while normal circulating desoxy-
corticosterone contributes little to total electrolyte control.
With few exceptions, however, the degree of alteration in
aldosterone secretion in disease processes is many times
that of other corticoids that have sodium-retaining properties,
and aldosterone is thus the mineralocorticoid par excellence.
However, in some cases of Cushing's syndrome and salt-
losing adrenogenital syndrome (described above), the
electrolyte disturbance is due to other adrenocorticoids
than aldosterone. While synergism or antagonism between
the actions of the currently known steroid hormones may
provide the correct explanation, it would appear that further
investigation of the 'amorphous' fraction of adrenal extracts
may prove profitable, since aldosterone may not be the only
sodium-retaining hormone of high potency.
Paradoxically, the discovery of ~dosterone has ~t off
an intensive search for sodium-diuretic hormones. Under
certain conditions (as yet not well defined), both cortisone
and cortisol will produce sodium' diuresis, possibly due to
their action in increasing the glomerular filtration rate. The
synthetic 'spirolactone' steroids73 ,74 only exert their sodium-
diuretic effect in the presence of desoxycorticosterone or
aldosterone, and suggest the tantalizing prospect that tI1e
adrenal gland may secrete a sodium-diuretic hormone.
While the discovery of aldosterone has solved one fragment
of the adrenocortical 'complex' and certain aspects of body-
fluid and electrolyte metabolism, it has posed further enigmas
for elucidation in the field of adrenal endocrinology.
I am indebted to Prof. C. H. Gray, Department of Chemical
Pathology, King's College Hospital· Medical School, London,
for laboratory facilities to develop methods of aldosterone estima-
tion, while holding a Cecil John Adams Fellowship in 1956.
I am also grateful to various workers (Drs. S. A. S. and J. F. Tait,
Middlesex Hospital; Drs. 1. H. Mills and R. V. Brooks, SI.
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Thomas's Hospital: Dr. R. eher, Ciba, Basle; Drs. R. Gaunt
and J. J. Chart, Ciba, ew Jersey; Dr. F.. C. Banter, ational
Institutes of Health, Bethesda; and Drs. R. Dorfman and O.
Hechter, Worcester Foundation for Experimental Biology, Shrews-
bury, Mass.); whose laboratones 1 had the opportunity and
pleasure of visiting.
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COMBINED ENTERIC INFECTION
KENNTIH C. WATSON, M.D., Department of Pathology, University of Natal, Durban
Enteric fever is a systemic clinical syndrome which may
result from infection with a variety of distinct but related
organisms of the salmonella group. In addition to classical
typhoid fever, due to Salmonella typhi, and paratyphoid
fever due to any of the three S. paratyphi strains, certain
other salmonella strains may produce the picture of enteric
. infection though the more usual result is an acute gastro-
enteritis. Chief amongst these according to Topley and
Wilson1 are S. cholera-suis, S. blegdam, S. dublin, S. enteri-
tidis var. chaco and S. sendai. .
Enteric infection associated with systemic invasion by
more than one organism of the salmonella group is by no
means common but occurs with sufficient frequency to make
the association a recognized entity. It was originally de-
scribed under the tenn jievre typhoide intriquee, by Chante-
messe and Grimberg,2 and the tenn 'double enteric infection'
was introduced by Shaw and MacKay.3 Several examples of
triple infection have however been recorded, and for this
reason we have preferred to use the term 'combined enteric
infection'. Shaw and MacKay's paper contains an extensive
review of the literature and they quote a series of 28 cases
of their own occurring in an epidemic outbreak in Ihe Middle
East. ·These infections.were due to S. typhi (Vi phage type T)
and S. paratyphi B (Vi phage type 'Dundee').
This brief report concerns a series of 4 cases of combined
infection due to S. typhi and S. dublin. In each case the
organisms were isolated from the blood stream. A 5th
patient is included where one of the organisms was isolated
from the blood and the other from the faeces. However,
it is uncertain whether this is a true example of combined
infection or whether the patient was a faecal carrier of one
type and merely had a superadded single infe<;tion with the
other organism.
PRESENT SERIES AND BACTERIOLOGICAL METHODS
Whole-blood cultures were performed by the addition of
approximately 8·0 m!. of blood to 50 ml. of bile-salt broth.
Clot cultures were made by the addition of the residual clot
